Hematology and Medical OncologyHematology and Medical OncologyChief： Prof. Shintaro KandaHematologyChief： Prof. Hideki MakishimaMedical Oncology・Molecular analysis of pathophysiology of myelodysplastic syndrome・Development of cellular immunotherapy for intractable hematological malignancies・Pathophysiological analysis of NK/T cell malignancy and development for its treatment・Pathophysiological analysis of and clinical research for large granular lymphocytic leukemia and pure red cell aplasia Understanding the etiology and pathophysiology of a disease may lead todevelopment of diagnosis and novel therapies. We believe that studying eachcase carefully is necessary for a clinician to unravel the complexity of the diseaseand to move into a new paradigm. It’d be a thrill and excitement for our team thatyou join us to feel such dynamism in your research and clinical work every day.・It is encouraged to hold proactive motivation to lead as a researcher or a clinician in our team or through corporative studies with other medical institutions・Self-development is encouraged to be a specialist with research-oriented mind in clinical hematology effects of immune checkpoint inhibitors and molecular targeted therapies.Hospitals in Nagano Prefecture and cancer gene panel tests nationwide.Training at a hospital oncology department in Nagano PrefectureStudy abroad in Japan (National Cancer Center etc.)Our missions in hematology cover a wide spectrum of diseases andconditions from a common illness to a rare disease entity. During frequentencounters with patients challenging intractable end of the spectrum ofhematological diseases at Shinshu University Hospital, we learn bothintensive/aggressive treatment style for a cure ofthe disease andrespectful/modest treatment style for enhancing the human dignity. Wetake best advantage of our teamwork for better treatment at the hospitaland for deeper understanding of the disease at our laboratory.Research subjectOutlook for researchOutlook for students after graduationWe are engaged in cancer treatment, education and research. TheDepartment of Medical Oncology provides drug therapy for cancersthroughout the body and also deals with malignant tumors that areoften difficult to diagnose and treat, such as rare cancers and cancersof unknown primary. We conduct cancer research from a cross-organand bird's-eye viewpoint. We design and perform clinical researchesbased on clinical questions that arise in the daily cancer care.Research subjectOutlook for researchOutlook for students after graduationpreparation for seq at ASHFigure in our article (Araki T, Kanda S, et al. Jpn J Clin Oncol 2023.)a clinical conferencepreparing a research papera hematopathological conferenceCancer genome expert panel in our hospitalOral presentation of research results at an international conference (Annual meeting of American Society of Clinical Oncology 2023)• Clinical trials of cancer treatment in collaboration with multicenter clinical research groups such as the Japanese Clinical Oncology Group (JCOG) and related facilities in Nagano Prefecture• Research to explore predictive markers of efficacy and risk factors for side • Clinical research utilizing data from the Cancer Genome Collaboration It is a great pleasure to discover new findings in the field of cancer, anintractable disease. Clinical research in the field of cancer is often conductedat multiple institutions, and you will make friendships with researchers atother institutions in the course of such collaborative research.• Qualification as a medical oncologist••33Feel the Dynamism of Hematology Foster professionals in the field of medical oncology and the clinical research
元のページ ../index.html#38